参考文献/References:
[1]Benjamin EJ,Muntner P,Alonso A,et al. Heart disease and stroke statistics—2019 update:a report from the American Heart Association[J]. Circulation,2019,139(10):e56-e528.
[2]World Health Organization. The top 10 causes of death[EB/OL]. (2018-05-24 ). https:/ /www.who. int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
[3]Lee YT,Lin HY,Chan YW,et al. Mouse models of atherosclerosis:a historical perspective and recent advances[J]. Lipids Health Dis,2017,16(1):12.
[4] Hossaini Nasr S,Tonson A,El-Dakdouki M,et al. Effects of nanoprobe morphology on cellular binding and inflammatory responses:hyaluronan-conjugated magnetic nanoworms for magnetic resonance imaging of atherosclerotic plaques[J]. ACS Appl Mater Interfaces,2018,10(14):11495-11507.
[5]Gao Z,Ma T,Zhao E,et al. Small is smarter:nano MRI contrast agents-advantages and recent achievements[J]. Small,2016,12(5):556-576.
[6]Zhao Y,Xiang L,Liu Y,et al. Atherosclerosis induced by a high-cholesterol and high-fat diet in the inbred strain of the Wuzhishan miniature pig[J]. Animal Biotechnol,2018,29(2):110-118.
[7] Emini Veseli B,Perrotta P,de Meyer GRA,et al. Animal models of atherosclerosis[J]. Eur J Pharmacol,2017,816:3-13.
[8]Fang B,Ren X,Wang Y,et al. Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs[J]. Dis Models Mech,2018,11(10):dmm036632.
[9]Pennesi ME,Neuringer M,Courtney RJ. Animal models of age related macular degeneration[J]. Mol Aspects Med,2012,33(4):487-509.
[10]Ogita M,Miyauchi K,Onishi A,et al. Development of accelerated coronary atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury[J]. PloS One,2016,11(9):e0163055.
[11] Thim T,Hagensen MK,Drouet L,et al. Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis:a model for preclinical studies[J]. EuroIntervention,2010,6(2):261-268.
[12]董莉,申强,郭淼,等. 黑血动态增强磁共振成像技术对早期动脉粥样硬化炎性反应的可行性研究[J]. 心肺血管病杂志,2019,38(8):874-878.
[13]Fatemeh RK,Gangadaran S,Li C,et al. Animal models of atherosclerosis[J]. World J Clin Cases,2014,2(5):126-132.
[14]Masley S,Kenney JJ,Novick JS. Optimal diets to prevent heart disease[J]. JAMA,2003,289(12):1510.
[15] Xu L,Wang R,Liu H,et al. Comparison of the diagnostic performances of ultrasound,high-resolution magnetic resonance imaging,and positron emission tomography/computed tomography in a rabbit carotid vulnerable plaque atherosclerosis model[J]. J Ultrasound Med,2020,39(11):2201-2209.
[16]Spartalis M,Spartalis E,Athanasiou A,et al.The role of the endothelium in premature atherosclerosis:molecular mechanisms[J]. Curr Med Chem,2020,27(7):1041-1051.
[17]唐曦,杨松,苟博,等. 高脂喂养联合免疫损伤建立兔动脉粥样硬化模型及评价 [J]. 中国医药导报,2016,13(18):21-24.
[18]Perevozchikov AP,Vaisman BL,Sorokin AV,et al. Study of the effect of the cDNA for the human A-I gene in transgenic rabbits:modeling the neurological syndrome of human Tangier disease[J]. Mol Biol(Mosk),1993,27(1):24-37.
[19]Emini Veseli B,Perrotta P,de Meyer GRA,et al. Animal models of atherosclerosis[J]. Eur J Pharmacol,2017,816:3-13.
[20] Weinreb DB,Aguinaldo JG,Feig JE,et al. Non-invasive MRI of mouse models of atherosclerosis[J]. NMR Biomed,2007,20(3):256-264.
[21]Hatters DM,Peters-Libeu CA,Weisgraber KH. Apolipoprotein E structure:insights into function[J]. Trends Biochem Sci,2006,31(8):445-454.
[22]杨梅,周建光,曹海涛,等.实验动物动脉粥样硬化模型的建立与评价[J]. 医疗装备,2010,23(6):35-37.
[23]Tani M,Matera R,Horvath KV,et al.The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans[J]. Atherosclerosis,2014,233(1):39-44.
[24]Burke AC,Huff MW. Regression of atherosclerosis:lessons learned from genetically modified mouse models[J]. Curr Opin Lipidol,2018,29(2):87-94.
[25]Liao J,Liu X,Gao M,et al. Dyslipidemia,steatohepatitis and atherogenesis in lipodystrophic ApoE deficient mice with Seipin deletion[J]. Gene,2018,648:82-88.
[26]孙明霞,冯越,谢敏. 靶向USPIO分子探针联合MR监测动脉粥样硬化细胞间黏附分子-1变化[J]. 心脑血管病学防治,2020,20(4),348-351.
[27]Choi YJ,Jung SC,Lee DH. Vessel wall imaging of the intracranial and cervical carotid arteries[J]. J Stroke,2015,17(3):238-255.
[28]Xu WH,Li ML,Niu JW,et al. Intracranial artery atherosclerosis and lumen dilation in cerebral small-vessel diseases:a high-resolution MRI Study[J]. Cns Neurosci Ther,2014,20(4):364-367.
[29] Wasserman BA,Smith WI,Trout HH 3rd,et al. Carotid artery atherosclerosis:in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results[J]. Radiology,2002,223(2):566-573.
[30] 徐永峰. 超高场磁共振成像射频线圈技术及实时监控系统的研究[D].中国科学技术大学,2017.
相似文献/References:
[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(8):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(8):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(8):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(8):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(8):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(8):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(8):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]